Searchable abstracts of presentations at key conferences in endocrinology

ea0096p21 | Section | UKINETS2023

The frequency of carcinoid heart disease in our neuroendocrine tumour cohort: a tertiary centre experience

Douglas Sasha , Batool Aaliya , Senthilvelavar Abishayini , Shah Tahir , Steeds Richard P

Introduction: Neuroendocrine tumours (NETs) can release harmful vasoactive substances into the systemic circulation, causing the characteristic features of carcinoid syndrome (CS) such as flushing, diarrhoea and bronchospasm. Approximately 20% of patients with CS develop carcinoid heart disease (CHD) due to progressive valve thickening, retraction and reduced mobility. CHD primarily affects the right-sided valves resulting in tricuspid and/or pulmonary regurgi...